| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |